Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Cascadian Therapeutics (CASC) Jumps: Stock Rises 10.4%
Cascadian Therapeutics, Inc. was a big mover last session, as the company saw its shares rise over 10% on the day. Shares gained after the company announced the pricing of the previously declared offering of 35,000,000 shares of its common stock at a price of 80 cents per share to the public. The news also led to far more shares changing hands than in a normal session, resulting in solid volume. This breaks the recent downtrend for the company as the stock is now below 21.5% in the past one-month time frame.
The company has seen one negative estimate revision over the past 30 days, while the Zacks Consensus Estimate remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cascadian Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Another better-ranked stock in the Biomedical industry is ANI Pharmaceuticals, Inc. (ANIP - Free Report) sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>